NO20051847L - Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. - Google Patents
Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi.Info
- Publication number
- NO20051847L NO20051847L NO20051847A NO20051847A NO20051847L NO 20051847 L NO20051847 L NO 20051847L NO 20051847 A NO20051847 A NO 20051847A NO 20051847 A NO20051847 A NO 20051847A NO 20051847 L NO20051847 L NO 20051847L
- Authority
- NO
- Norway
- Prior art keywords
- neurosis
- bulimia
- anorexia
- epa
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Eikosapentaensyre (EPA) anvendes i behandlingen av anoreksia nevrosa, bulimi og relaterte kliniske syndromer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0221480.7A GB0221480D0 (en) | 2002-09-16 | 2002-09-16 | Treatment of anorexia nervosa (AN) and bulimia |
PCT/GB2003/003985 WO2004024136A1 (en) | 2002-09-16 | 2003-09-16 | Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051847L true NO20051847L (no) | 2005-04-15 |
Family
ID=9944164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051847A NO20051847L (no) | 2002-09-16 | 2005-04-15 | Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060135608A1 (no) |
EP (1) | EP1556028A1 (no) |
JP (1) | JP2006503031A (no) |
KR (1) | KR20050042823A (no) |
CN (1) | CN1694694A (no) |
AU (1) | AU2003269138A1 (no) |
BR (1) | BR0317857A (no) |
CA (1) | CA2499142A1 (no) |
GB (1) | GB0221480D0 (no) |
HR (1) | HRP20050245A2 (no) |
IS (1) | IS7744A (no) |
MX (1) | MXPA05002943A (no) |
NO (1) | NO20051847L (no) |
NZ (1) | NZ538793A (no) |
PL (1) | PL375726A1 (no) |
RS (1) | RS20050226A (no) |
RU (1) | RU2330653C2 (no) |
TW (1) | TW200410682A (no) |
WO (1) | WO2004024136A1 (no) |
ZA (1) | ZA200502161B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
WO2005046668A1 (ja) * | 2003-11-14 | 2005-05-26 | Mochida Pharmaceutical Co., Ltd. | 言語障害予防・治療剤 |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
WO2008081989A1 (ja) | 2006-12-28 | 2008-07-10 | Suntory Holdings Limited | 神経再生剤 |
US8816110B2 (en) | 2007-02-15 | 2014-08-26 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
DK2121576T3 (en) | 2007-02-15 | 2016-02-15 | Ct De Rech Sur Les Biotechnologies Marine | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
WO2008113177A1 (en) | 2007-03-20 | 2008-09-25 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US8455472B2 (en) * | 2009-06-15 | 2013-06-04 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
KR20140007430A (ko) * | 2011-02-11 | 2014-01-17 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 에이코사펜타엔산 농축물 |
US9447020B2 (en) | 2013-10-31 | 2016-09-20 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
RU2545988C1 (ru) * | 2013-11-12 | 2015-04-10 | Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы | Способ лечения хронического запора и функциональной анорексии |
CN111971041A (zh) | 2018-02-07 | 2020-11-20 | Scf制药股份有限公司 | 多不饱和脂肪酸单甘油酯、组合物、方法及其用途 |
WO2019204218A1 (en) * | 2018-04-16 | 2019-10-24 | Quadrant Biosciences Inc. | Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status |
AU2019264159A1 (en) | 2018-05-03 | 2020-12-24 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
CN109276262B (zh) * | 2018-07-30 | 2021-01-26 | 中国科学院心理研究所 | 一种用于筛选高危进食障碍的检测系统 |
US20210299065A1 (en) * | 2020-03-27 | 2021-09-30 | Homeostasis Therapeutics, Limited | Methods of treatment for anorexia nervosa, bulimia and related clinical syndromes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
-
2002
- 2002-09-16 GB GBGB0221480.7A patent/GB0221480D0/en not_active Ceased
-
2003
- 2003-09-16 RU RU2005107416/14A patent/RU2330653C2/ru not_active IP Right Cessation
- 2003-09-16 RS YUP-2005/0226A patent/RS20050226A/sr unknown
- 2003-09-16 CN CNA038251698A patent/CN1694694A/zh active Pending
- 2003-09-16 JP JP2004535695A patent/JP2006503031A/ja active Pending
- 2003-09-16 NZ NZ538793A patent/NZ538793A/en unknown
- 2003-09-16 TW TW092125483A patent/TW200410682A/zh unknown
- 2003-09-16 US US10/528,114 patent/US20060135608A1/en not_active Abandoned
- 2003-09-16 BR BR0317857-9A patent/BR0317857A/pt not_active IP Right Cessation
- 2003-09-16 MX MXPA05002943A patent/MXPA05002943A/es not_active Application Discontinuation
- 2003-09-16 EP EP03750919A patent/EP1556028A1/en not_active Ceased
- 2003-09-16 WO PCT/GB2003/003985 patent/WO2004024136A1/en active Application Filing
- 2003-09-16 KR KR1020057004483A patent/KR20050042823A/ko not_active Application Discontinuation
- 2003-09-16 AU AU2003269138A patent/AU2003269138A1/en not_active Abandoned
- 2003-09-16 PL PL03375726A patent/PL375726A1/xx not_active Application Discontinuation
- 2003-09-16 CA CA002499142A patent/CA2499142A1/en not_active Abandoned
-
2005
- 2005-03-15 ZA ZA200502161A patent/ZA200502161B/en unknown
- 2005-03-15 IS IS7744A patent/IS7744A/is unknown
- 2005-03-16 HR HR20050245A patent/HRP20050245A2/hr not_active Application Discontinuation
- 2005-04-15 NO NO20051847A patent/NO20051847L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2330653C2 (ru) | 2008-08-10 |
JP2006503031A (ja) | 2006-01-26 |
GB0221480D0 (en) | 2002-10-23 |
WO2004024136A1 (en) | 2004-03-25 |
ZA200502161B (en) | 2005-09-15 |
RS20050226A (en) | 2007-09-21 |
RU2005107416A (ru) | 2006-01-20 |
CA2499142A1 (en) | 2004-03-25 |
HRP20050245A2 (en) | 2005-10-31 |
CN1694694A (zh) | 2005-11-09 |
BR0317857A (pt) | 2005-12-06 |
PL375726A1 (en) | 2005-12-12 |
TW200410682A (en) | 2004-07-01 |
EP1556028A1 (en) | 2005-07-27 |
US20060135608A1 (en) | 2006-06-22 |
AU2003269138A1 (en) | 2004-04-30 |
NZ538793A (en) | 2007-05-31 |
MXPA05002943A (es) | 2005-06-03 |
IS7744A (is) | 2005-03-15 |
KR20050042823A (ko) | 2005-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051847L (no) | Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. | |
ATE423559T1 (de) | Kombinationstherapie durch glukoseresorptionshemmer und ppar modulatoren | |
RS93604A (en) | Substituted phenylacetamides and their use as glucokinase activators | |
AU2003295912A1 (en) | Electro-osmotic pumps and micro-channels | |
DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
TR200200160T2 (tr) | Antiinflamatuar ajanlar olarak imidazoller ve triazoller | |
DE60111570D1 (de) | Isoindolin-1-on als glukokinaseaktivatoren | |
BR0312785A (pt) | Tratamento de desordens relacionadas a tnf(alfa) | |
SE0102315D0 (sv) | Compounds | |
RS20060320A (en) | Substituted indazole-o-glucosides | |
NO20055741D0 (no) | Nye kjemiske forbindelser | |
SG130189A1 (en) | Substituted indole-o-glucosides | |
NO20071378L (no) | Tiazolo-naftylsyrer. | |
IS7858A (is) | Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD) | |
NO20024240L (no) | Nye arylfruktose-1,6-bisfosfataseinhibitorer | |
ATE312096T1 (de) | Neue verbindungen | |
BR0315644A (pt) | Piperazinil e diazapanil benzamidas e benzotioamidas | |
DK1648484T3 (da) | Fremgangsmåde til behandling af arthritis-tilstande | |
NO20010860L (no) | Nye forbindelser | |
GB2399019B (en) | The structure containing the conductive medium for the source of the external high-power focusing ultrasonic treatment | |
PT1419163E (pt) | Imidazopiridinas triciclicas | |
DE60305522D1 (de) | Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer | |
ATE417856T1 (de) | Motilidverbindungen | |
DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |